Skip Nav Destination
Issues
Featured Articles
Perspective
Cooperative Group Bulletin Board
Cancer and Leukemia Group B 90206: A Randomized Phase III Trial of Interferon-α or Interferon-α Plus Anti-Vascular Endothelial Growth Factor Antibody (Bevacizumab) in Metastatic Renal Cell Carcinoma
Brian I. Rini; Susan Halabi; John Taylor; Eric J. Small; Richard L. Schilsky; for the Cancer Leukemia Group B
Clinical Trials
Evidence That Transfer of Functional p53 Protein Results in Increased Apoptosis in Prostate Cancer
Louis L. Pisters; Curtis A. Pettaway; Patricia Troncoso; Timothy J. McDonnell; L. Clifton Stephens; Christopher G. Wood; Kim-Anh Do; Shawn M. Brisbay; Xuemei Wang; Elizabeth A. Hossan; Robert B. Evans; Cindy Soto; Marc G. Jacobson; Karen Parker; James A. Merritt; Mitchell S. Steiner; Christopher J. Logothetis
Molecular Oncology, Markers, Clinical Correlates
Matrix Metalloproteinase 3 Polymorphism: A Predictive Factor of Response to Neoadjuvant Chemotherapy in Head and Neck Squamous Cell Carcinoma
Hélène Blons; Sophie Gad; Franck Zinzindohoué; Isabelle Manière; Janie Beauregard; David Tregouet; Daniel Brasnu; Philippe Beaune; Ollivier Laccourreye; Pierre Laurent-Puig
Regular Articles
Clinical Trials
Intratumoral Administration of Recombinant Human Interleukin 12 in Head and Neck Squamous Cell Carcinoma Patients Elicits a T-Helper 1 Profile in the Locoregional Lymph Nodes
Carla M. van Herpen; Maaike Looman; Marijke Zonneveld; Nicole Scharenborg; Peter C. de Wilde; Louis van de Locht; Matthias A. W. Merkx; Gosse J. Adema; Pieter H. De Mulder
A Phase I Pharmacokinetic and Pharmacodynamic Study of the Farnesyl Transferase Inhibitor BMS-214662 in Combination with Cisplatin in Patients with Advanced Solid Tumors
Helen J. Mackay; Ronald Hoekstra; Ferry A. L. M. Eskens; Walker J. Loos; Donna Crawford; Maurizio Voi; Anne Van Vreckem; T. R. Jeffrey Evans; Jaap Verweij
Generation of Carcinoembryonic Antigen (CEA)-Specific T-Cell Responses in HLA-A*0201 and HLA-A*2402 Late-Stage Colorectal Cancer Patients after Vaccination with Dendritic Cells Loaded with CEA Peptides
Ko-Jiunn Liu; Chuan-Cheng Wang; Li-Tzong Chen; Ann-Lii Cheng; Dong-Tsamn Lin; Yu-Chen Wu; Wei-Lan Yu; Yi-Mei Hung; Hui-Yu Yang; Shin-Hun Juang; Jacqueline Whang-Peng
Research Articles
Molecular Oncology, Markers, Clinical Correlates
Epithelial Cell Adhesion Molecule (KSA) Expression: Pathobiology and Its Role as an Independent Predictor of Survival in Renal Cell Carcinoma
David B. Seligson; Allan J. Pantuck; Xueli Liu; Yunda Huang; Steven Horvath; Matthew H. T. Bui; Ken-ryu Han; Adrian J. L. Correa; Mervi Eeva; Sheila Tze; Arie S. Belldegrun; Robert A. Figlin
Detection of Residual Subclinical Ovarian Carcinoma after Completion of Adjuvant Chemotherapy
Mory Nouriani; Afshin Bahador; Jonathan S. Berek; Joan P. Cheng; Dennis S. Chi; William A. Cliby; Giuseppe Del Priore; Mark K. Dodson; Bridgette D. Duggan; David M. Gershenson; Scott E. Lentz; Richard T. Penson; William R. Robinson; Mildred Rodriguez; Lynda D. Roman; Mimi C. Yu; Karen Zempolich; Louis Dubeau
Decreased Expression of 14-3-3σ Is Associated with Advanced Disease in Human Epithelial Ovarian Cancer: Its Correlation with Aberrant DNA Methylation
Jun-ichi Akahira; Youko Sugihashi; Takashi Suzuki; Kiyoshi Ito; Hitoshi Niikura; Takuya Moriya; Makoto Nitta; Hitoshi Okamura; Satoshi Inoue; Hironobu Sasano; Kunihiro Okamura; Nobuo Yaegashi
Cyclooxygenase-2 Activation Mediates the Proangiogenic Effect of Nitric Oxide in Colorectal Cancer
Fabio Cianchi; Camillo Cortesini; Ornella Fantappiè; Luca Messerini; Iacopo Sardi; Nadia Lasagna; Federico Perna; Valentina Fabbroni; Annamaria Di Felice; Giuliano Perigli; Roberto Mazzanti; Emanuela Masini
Nuclear Localization of KLF4 Is Associated with an Aggressive Phenotype in Early-Stage Breast Cancer
Ashka Y. Pandya; Lynya I. Talley; Andra R. Frost; Thomas J. Fitzgerald; Vivek Trivedi; Mithun Chakravarthy; David C. Chhieng; William E. Grizzle; Jeffrey A. Engler; Helen Krontiras; Kirby I. Bland; Albert F. LoBuglio; Susan M. Lobo-Ruppert; J. Michael Ruppert
Prognostic Analysis of E-Cadherin Gene Promoter Hypermethylation in Patients with Surgically Resected, Node-Positive, Diffuse Gastric Cancer
Francesco Graziano; Federica Arduini; Annamaria Ruzzo; Italo Bearzi; Bostjan Humar; Helen More; Rosarita Silva; Pietro Muretto; Parry Guilford; Enrica Testa; Davide Mari; Mauro Magnani; Stefano Cascinu
MUC1 and Nuclear β-Catenin Are Coexpressed at the Invasion Front of Colorectal Carcinomas and Are Both Correlated with Tumor Prognosis
Stephan E. Baldus; Stefan P. Mönig; Sandra Huxel; Stephanie Landsberg; Franz-Georg Hanisch; Katja Engelmann; Paul M. Schneider; Jürgen Thiele; Arnulf H. Hölscher; Hans P. Dienes
Prognostic Value of the Cu-Transporting ATPase in Ovarian Carcinoma Patients Receiving Cisplatin-Based Chemotherapy
Kentaro Nakayama; Atsuko Kanzaki; Kunihiko Terada; Masato Mutoh; Kenji Ogawa; Toshihiro Sugiyama; Seiichi Takenoshita; Kiyoshi Itoh; Nobuo Yaegashi; Kohji Miyazaki; Nouri Neamati; Yuji Takebayashi
Prognostic Value of CD40 in Adult Soft Tissue Sarcomas
Alessandro Ottaiano; Anna De Chiara; Francesco Perrone; Gerardo Botti; Flavio Fazioli; Vincenzo De Rosa; Nicola Mozzillo; Vincenzo Ravo; Brunello Morrica; Ciro Gallo; Carmela Pisano; Maria Napolitano; Paolo Antonio Ascierto; Rosario Vincenzo Iaffaioli; Gaetano Apice
Experimental Therapeutics, Preclinical Pharmacology
Characterization of a New Humanized Anti-CD20 Monoclonal Antibody, IMMU-106, and Its Use in Combination with the Humanized Anti-CD22 Antibody, Epratuzumab, for the Therapy of Non-Hodgkin’s Lymphoma
Rhona Stein; Zhengxing Qu; Susan Chen; Adriane Rosario; Victoria Shi; Marianne Hayes; Ivan D. Horak; Hans J. Hansen; David M. Goldenberg
NY-ESO-1 Protein Formulated in ISCOMATRIX Adjuvant Is a Potent Anticancer Vaccine Inducing Both Humoral and CD8+ T-Cell-Mediated Immunity and Protection against NY-ESO-1+ Tumors
Eugene Maraskovsky; Sigrid Sjölander; Debbie P. Drane; Max Schnurr; Thuy T. T. Le; Luis Mateo; Thomas Luft; Kelly-Anne Masterman; Tsin-Yee Tai; Qiyuan Chen; Simon Green; Anders Sjölander; Martin J. Pearse; Francois A. Lemonnier; Weisan Chen; Jonathan Cebon; Andreas Suhrbier
Intratumoral Administration of Dendritic Cells Overexpressing CCL21 Generates Systemic Antitumor Responses and Confers Tumor Immunity
Seok-Chul Yang; Sven Hillinger; Karen Riedl; Ling Zhang; Li Zhu; Min Huang; Kimberly Atianzar; Brian Y. Kuo; Brian Gardner; Raj K. Batra; Robert M. Strieter; Steven M. Dubinett; Sherven Sharma
Letters to the Editor
Correspondence re L. J. Wirth et al., Induction Docetaxel and Carboplatin Followed by Weekly Docetaxel and Carboplatin with Concurrent Radiotherapy, Then Surgery in Stage III Non-Small Cell Lung Cancer: a Phase I Study. Clin Cancer Res 2003;9:1698–704.
Alfredo Cesario; Stefano Margaritora; Domenico Galetta; Venanzio Porziella; Pierluigi Granone; Rolando Maria D’Angelillo; Lucio Trodella; Vittorio Cardaci; Silvia Sterzi; Patrizia Russo
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.
RSS Feeds